Back to news

D-Wave Customer Shionogi Wins First Place in NEDO Quantum Computing Challenge’s Quality of Life Category

Business Wire•28/10/2026•07:00 ET
6

Key Highlights

  • ➤Shionogi wins first place in NEDO’s Quality of Life quantum computing category
  • ➤¥40 million prize funds Shionogi’s continued quantum-assisted drug discovery research
  • ➤Quantum-assisted model produced 97% chemically valid molecules versus 73% classically
  • ➤Quantum-assisted model generated more molecules with strong drug-likeness scores than comparators

Expert Statements

Dr. Alan Baratz, CEO of D-Wave

“We believe that combining quantum computing with AI has the potential to accelerate scientific progress and open new paths to solving some of the world’s most consequential problems.”

Dr. Alan Baratz, CEO of D-Wave

“Our collaboration with Shionogi on this study demonstrates that annealing quantum computing can help a generative AI model produce higher-quality molecules for drug discovery.”

Dr. Alan Baratz, CEO of D-Wave

“By helping researchers identify more promising molecules earlier in the process, this approach could ultimately contribute to better treatments and improved patient outcomes.”

Dr. Hayato Kunugi, Senior research scientist at Shionogi and lead author of the research published in Scientific Reports

“The NEDO award will help us advance our cutting-edge research in quantum-assisted drug discovery.”

Dr. Hayato Kunugi, Senior research scientist at Shionogi and lead author of the research published in Scientific Reports

“Our research combines quantum computing and high-performance computing to generate and evaluate drug candidate molecules.”

Dr. Hayato Kunugi, Senior research scientist at Shionogi and lead author of the research published in Scientific Reports

“As one part of these efforts, our study using D-Wave technology showed that a quantum-assisted generative AI model could produce higher-quality candidate molecules, suggesting the potential to improve the efficiency of early-stage molecular design.”

Dr. Hayato Kunugi, Senior research scientist at Shionogi and lead author of the research published in Scientific Reports

“We hope this work will ultimately contribute to faster development of new medicines for the patients we serve.”

D-Wave Customer Shionogi Wins First Place in NEDO Quantum Computing Challenge’s Quality of Life Category

¥40 million prize will support continued research exploring the application of quantum computing to drug discovery, with achievements including, among others, a peer-reviewed study using D-Wave’s annealing quantum computing technology

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in